Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias. (2021)

Record Type:
Journal Article
Title:
Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias. (2021)
Main Title:
Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias
Authors:
Sinha, Neelam
Sinha, Sanju
Cheng, Kuoyuan
Madan, Sanna
Erez, Ayelet
Ryan, Bríd M.
Schäffer, Alejandro A.
Aldape, Kenneth
Ruppin, Eytan
Abstract:
Is Part Of:
JCO precision oncology. Volume 5(2021)
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Issue Display:
Volume 5, Issue 2021 (2021)
Year:
2021
Volume:
5
Issue:
2021
Issue Sort Value:
2021-0005-2021-0000
Page Start:
Page End:
Publication Date:
2021
Subjects:
Precision Medicine
Neoplasms
Pharmacogenetics
Molecular Targeted Therapy
Personalized medicine
Oncology
Pharmacogenomics
Periodical
Periodicals
616.994
Journal URLs:
http://po.jco.org ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1200/PO.21.00168 ↗
Languages:
English
ISSNs:
2473-4284
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
22883.xml